Jci_page_head_homepage_01 Jci_page_head_homepage_02
Yingmei Liu, Guoyong Yin, James Surapisitchat, Bradford C. Berk, Wang Min
Published in Volume 107, Issue 7
J Clin Invest. 2001; 107(7):917–923 doi:10.1172/JCI11947
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

Flow enhances the interaction of ASK1 with its inhibitor 14-3-3. HUVECs were subjected to flow and TNF treatment as described in Figure 1. Cell lysates were immunoprecipitated (IP) with Ab against 14-3-3 followed by an immunoblot (IB) analysis with anti-ASK1 (top panel). The 14-3-3 protein in the immunoprecipitates was determined by Western blot analysis with Ab against 14-3-3 (lower panel).